Gail Frances McIntyre, Senior Vice President-Research at Furiex Pharmaceuticals, Inc. (FURX), sold 20,000 shares at $40.00 ($800K) on 2013-07-19, disclosed to the SEC on 2013-09-18.
Scheduled sale ($800k) by Senior Vice President-Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FURX | SELL | 2014-06-18 | $7.8M | — | Filing → |
| FURX | SELL | 2014-06-12 | $183K | — | Filing → |
| FURX | SELL | 2013-07-23 | $423K | — | Filing → |